{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "26600256", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.1097/EDE.0000000000000421"], "Journal": {"ISSN": "1531-5487", "JournalIssue": {"Volume": "27", "Issue": "2", "PubDate": {"Year": "2016", "Month": "Mar"}}, "Title": "Epidemiology (Cambridge, Mass.)", "ISOAbbreviation": "Epidemiology"}, "ArticleTitle": "Long- and Short-term Exposure to Air Pollution and Inflammatory/Hemostatic Markers in Midlife Women.", "Pagination": {"StartPage": "211", "EndPage": "220", "MedlinePgn": "211-20"}, "Abstract": {"AbstractText": ["Studies have reported associations between long-term air pollution exposures and cardiovascular mortality. The biological mechanisms connecting them remain uncertain.", "We examined associations of fine particles (PM2.5) and ozone with serum markers of cardiovascular disease risk in a cohort of midlife women. We obtained information from women enrolled at six sites in the multi-ethnic, longitudinal Study of Women's Health Across the Nation, including repeated measurements of high-sensitivity C-reactive protein, fibrinogen, tissue-type plasminogen activator antigen, plasminogen activator inhibitor type 1, and factor VIIc (factor VII coagulant activity). We obtained residence-proximate PM2.5 and ozone monitoring data for a maximum five annual visits, calculating prior year, 6-month, 1-month, and 1-day exposures and their relations to serum markers using longitudinal mixed models.", "For the 2,086 women studied from 1999 to 2004, PM2.5 exposures were associated with all blood markers except factor VIIc after adjusting for age, race/ethnicity, education, site, body mass index, smoking, and recent alcohol use. Adjusted associations were strongest for prior year exposures for high-sensitivity C-reactive protein (21% increase per 10 \u03bcg/m\u00b3 PM2.5, 95% confidence interval [CI]: 6.6, 37), tissue-type plasminogen activator antigen (8.6%, 95% CI: 1.8, 16), and plasminogen activator inhibitor (35%, 95% CI: 19, 53). An association was also observed between year prior ozone exposure and factor VIIc (5.7% increase per 10 ppb ozone, 95% CI: 2.9, 8.5).", "Our findings suggest that prior year exposures to PM2.5 and ozone are associated with adverse effects on inflammatory and hemostatic pathways for cardiovascular outcomes in midlife women."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the aOffice of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA; bDepartment of Public Health Sciences, University of California Davis School of Medicine, Davis, CA; cKaiser Permanente Division of Research, Oakland, CA; dDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; eDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA; fDepartment of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA; gRush University Medical Center, Chicago, IL; hSchool of Public Health, University of Michigan, Ann Arbor, MI; iSaul R. Korey Department of Neurology, and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY; and jDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Hospital and Health Systems, Ann Arbor, MI."}], "LastName": "Green", "ForeName": "Rochelle", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Broadwin", "ForeName": "Rachel", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Malig", "ForeName": "Brian", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Basu", "ForeName": "Rupa", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gold", "ForeName": "Ellen B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Qi", "ForeName": "Lihong", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sternfeld", "ForeName": "Barbara", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Bromberger", "ForeName": "Joyce T", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Greendale", "ForeName": "Gail A", "Initials": "GA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kravitz", "ForeName": "Howard M", "Initials": "HM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tomey", "ForeName": "Kristin", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Matthews", "ForeName": "Karen", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Derby", "ForeName": "Carol A", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jackson", "ForeName": "Elizabeth A", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Green", "ForeName": "Robin", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ostro", "ForeName": "Bart", "Initials": "B"}], "GrantList": [{"GrantID": "U01AG012535", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012554", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012546", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012495", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "UL1 RR024131", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012531", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012505", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012539", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012535", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012553", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 NR004061", "Acronym": "NR", "Agency": "NINR NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012539", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012554", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012546", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012495", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012505", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01 AG012531", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}, {"GrantID": "U01NR004061", "Acronym": "NR", "Agency": "NINR NIH HHS", "Country": "United States"}, {"GrantID": "U01AG012553", "Acronym": "AG", "Agency": "NIA NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Epidemiology", "NlmUniqueID": "9009644", "ISSNLinking": "1044-3983"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antigens"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Particulate Matter"}, {"RegistryNumber": "0", "NameOfSubstance": "Plasminogen Activator Inhibitor 1"}, {"RegistryNumber": "0", "NameOfSubstance": "SERPINE1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "factor VII clotting antigen"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9001-25-6", "NameOfSubstance": "Factor VII"}, {"RegistryNumber": "9001-32-5", "NameOfSubstance": "Fibrinogen"}, {"RegistryNumber": "9007-41-4", "NameOfSubstance": "C-Reactive Protein"}, {"RegistryNumber": "EC 3.4.21.68", "NameOfSubstance": "Tissue Plasminogen Activator"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["statistics & numerical data"], "DescriptorName": "Air Pollution"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antigens"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["metabolism"], "DescriptorName": "C-Reactive Protein"}, {"QualifierName": [], "DescriptorName": "Cohort Studies"}, {"QualifierName": ["statistics & numerical data"], "DescriptorName": "Environmental Exposure"}, {"QualifierName": ["metabolism"], "DescriptorName": "Factor VII"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Fibrinogen"}, {"QualifierName": [], "DescriptorName": "Hemostasis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Longitudinal Studies"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Particulate Matter"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plasminogen Activator Inhibitor 1"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tissue Plasminogen Activator"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356(5):447\u201358.", "ArticleIdList": ["17267905"]}, {"Citation": "Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med. 2006;173(6):667\u201372.", "ArticleIdList": ["PMC2662950", "16424447"]}, {"Citation": "Peel JL, Metzger KB, Klein M, Flanders WD, Mulholland JA, Tolbert PE. Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups. Am J Epidemiol. 2007;165(6):625\u201333.", "ArticleIdList": ["17194748"]}, {"Citation": "Urch B, Speck M, Corey P, Wasserstein D, Manno M, Lukic KZ, Brook JR, Liu L, Coull B, Schwartz J, Gold DR, Silverman F. Concentrated ambient fine particles and not ozone induce a systemic interleukin-6 response in humans. Inhal Toxicol. 2010;22(3):210\u20138.", "ArticleIdList": ["PMC4755272", "20088738"]}, {"Citation": "Brook RD, Rajagopalan S, Pope CA, III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC, Jr, Whitsel L, Kaufman JD. Epidemiology obotAHACo, Prevention CotKiCD, Council on Nutrition PA, Metabolism. Particulate Matter Air Pollution and Cardiovascular Disease. An Update to the Scientific Statement From the American Heart Association. Circulation. 2010:CIR.0b013e3181dbece1.", "ArticleIdList": ["20458016"]}, {"Citation": "Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279(18):1477\u201382.", "ArticleIdList": ["9600484"]}, {"Citation": "Emerging Risk Factors C. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D'Agostino RB, Sr., Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engstrom G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310\u201320.", "ArticleIdList": ["PMC3714101", "23034020"]}, {"Citation": "Ridker PM. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J. 2005;32(3):384\u20136.", "ArticleIdList": ["PMC1336715", "16392225"]}, {"Citation": "Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, Rumley A, Whincup PH. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J. 2004;25(3):252\u20139.", "ArticleIdList": ["14972427"]}, {"Citation": "Macko RF, Kittner SJ, Epstein A, Cox DK, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, McCarter RJ, Johnson CJ, Earley CJ, Buchholz DW, Stolley PD. Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study. Stroke. 1999;30(1):7\u201311.", "ArticleIdList": ["9880380"]}, {"Citation": "Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation. 2005;112(20):3080\u20137.", "ArticleIdList": ["16286603"]}, {"Citation": "Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol. 2000;20(8):2019\u201323.", "ArticleIdList": ["10938026"]}, {"Citation": "Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke. 1996;27(6):1066\u201371.", "ArticleIdList": ["8650716"]}, {"Citation": "Zakai NA, Lange L, Longstreth WT, Jr., O'Meara ES, Kelley JL, Fornage M, Nikerson D, Cushman M, Reiner AP. Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study. J Thromb Haemost. 2011;9(2):267\u201374.", "ArticleIdList": ["PMC3030667", "21114618"]}, {"Citation": "Diez Roux AV, Auchincloss AH, Astor B, Barr RG, Cushman M, Dvonch T, Jacobs DR, Jr., Kaufman J, Lin X, Samson P. Recent exposure to particulate matter and C-reactive protein concentration in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2006;164(5):437\u201348.", "ArticleIdList": ["16751260"]}, {"Citation": "Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F, Sioutas C. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect. 2008;116(7):898\u2013906.", "ArticleIdList": ["PMC2453158", "18629312"]}, {"Citation": "Rioux CL, Tucker KL, Mwamburi M, Gute DM, Cohen SA, Brugge D. Residential Traffic Exposure, Pulse Pressure and C-Reactive Protein: Consistency and Contrast Among Exposure Characterization Methods. Environ Health Perspect. 2010", "ArticleIdList": ["PMC2898857", "20123638"]}, {"Citation": "Hennig F, Fuks K, Moebus S, Weinmayr G, Memmesheimer M, Jakobs H, Brocker-Preuss M, Fuhrer-Sakel D, Mohlenkamp S, Erbel R, Jockel KH, Hoffmann B. Association between Source-Specific Particulate Matter Air Pollution and hs-CRP: Local Traffic and Industrial Emissions. Environ Health Perspect. 2014;122(7):703\u201310.", "ArticleIdList": ["PMC4080540", "24755038"]}, {"Citation": "Forbes LJ, Patel MD, Rudnicka AR, Cook DG, Bush T, Stedman JR, Whincup PH, Strachan DP, Anderson RH. Chronic exposure to outdoor air pollution and markers of systemic inflammation. Epidemiology. 2009;20(2):245\u201353.", "ArticleIdList": ["19234416"]}, {"Citation": "Emmerechts J, Jacobs L, Van Kerckhoven S, Loyen S, Mathieu C, Fierens F, Nemery B, Nawrot TS, Hoylaerts MF. Air pollution-associated procoagulant changes: the role of circulating microvesicles. J Thromb Haemost. 2012;10(1):96\u2013106.", "ArticleIdList": ["22066779"]}, {"Citation": "Ostro B, Malig B, Broadwin R, Basu R, Gold EB, Bromberger JT, Derby C, Feinstein S, Greendale GA, Jackson EA, Kravitz HM, Matthews KA, Sternfeld B, Tomey K, Green RR, Green R. Chronic PM2.5 exposure and inflammation: determining sensitive subgroups in mid-life women. Environ Res. 2014;132:168\u201375.", "ArticleIdList": ["PMC4314307", "24792413"]}, {"Citation": "Sowers MF, Crawford S, Sternfield B, Morganstein D, Gold E, Greendale G, Evans D, Neer R, Matthews K, Sherman S, Lo A, Weiss G, Kelsey J. SWAN: A Multicenter, Multiethnic, Community-Based Cohort Study of Women and the Menopausal Transition. Women's Faculty Committee Publications and Presentations. 2000:175\u2013188."}, {"Citation": "Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Crandall CJ, Gold E, Sternfeld B, Selzer F, Matthews KA. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause. 2011;18(10):1044\u201351.", "ArticleIdList": ["PMC3183159", "21926929"]}, {"Citation": "U.S. EPA. Air Quality System Data Mart. U.S. EPA; 2010."}, {"Citation": "O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, Horton ES, Schwartz J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111(22):2913\u201320.", "ArticleIdList": ["15927967"]}, {"Citation": "Weichenthal S, Villeneuve PJ, Burnett RT, van Donkelaar A, Martin RV, Jones RR, DellaValle CT, Sandler DP, Ward MH, Hoppin JA. Long-Term Exposure to Fine Particulate Matter: Association with Nonaccidental and Cardiovascular Mortality in the Agricultural Health Study Cohort. Environ Health Perspect. 2014;122(6):609\u2013615.", "ArticleIdList": ["PMC4050514", "24633320"]}, {"Citation": "O'Neill MS, Veves A, Sarnat JA, Zanobetti A, Gold DR, Economides PA, Horton ES, Schwartz J. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med. 2007;64(6):373\u20139.", "ArticleIdList": ["PMC2078522", "17182639"]}, {"Citation": "Riediker M, Devlin RB, Griggs TR, Herbst MC, Bromberg PA, Williams RW, Cascio WE. Cardiovascular effects in patrol officers are associated with fine particulate matter from brake wear and engine emissions. Part Fibre Toxicol. 2004;1(1):2.", "ArticleIdList": ["PMC1074349", "15813985"]}, {"Citation": "Liu L, Ruddy TD, Dalipaj M, Szyszkowicz M, You H, Poon R, Wheeler A, Dales R. Influence of personal exposure to particulate air pollution on cardiovascular physiology and biomarkers of inflammation and oxidative stress in subjects with diabetes. J Occup Environ Med. 2007;49(3):258\u201365.", "ArticleIdList": ["17351511"]}, {"Citation": "Zeka A, Sullivan JR, Vokonas PS, Sparrow D, Schwartz J. Inflammatory markers and particulate air pollution: characterizing the pathway to disease. Int J Epidemiol. 2006;35(5):1347\u201354.", "ArticleIdList": ["16844771"]}, {"Citation": "Hoffmann B, Moebus S, Dragano N, Stang A, Mohlenkamp S, Schmermund A, Memmesheimer M, Brocker-Preuss M, Mann K, Erbel R, Jockel KH. Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers. Environ Health Perspect. 2009;117(8):1302\u20138.", "ArticleIdList": ["PMC2721876", "19672412"]}, {"Citation": "Chen R, Zhao Z, Sun Q, Lin Z, Zhao A, Wang C, Xia Y, Xu X, Kan H. Size-fractionated Particulate Air Pollution and Circulating Biomarkers of Inflammation, Coagulation, and Vasoconstriction in a Panel of Young Adults. Epidemiology. 2015;26(3):328\u201336.", "ArticleIdList": ["25738902"]}, {"Citation": "Li Y, Rittenhouse-Olson K, Scheider WL, Mu L. Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies. Rev Environ Health. 2012;27(2-3):133\u201349.", "ArticleIdList": ["PMC3559179", "23023922"]}, {"Citation": "Thompson AM, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, Speck M, Brook JR, Manno M, Gold DR. Baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect. 2010;118(1):120\u20134.", "ArticleIdList": ["PMC2831955", "20056584"]}, {"Citation": "Pekkanen J, Brunner EJ, Anderson HR, Tiittanen P, Atkinson RW. Daily concentrations of air pollution and plasma fibrinogen in London. Occup Environ Med. 2000;57(12):818\u201322.", "ArticleIdList": ["PMC1739901", "11077010"]}, {"Citation": "Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann HE, Peters A. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006;173(4):432\u201341.", "ArticleIdList": ["16293802"]}, {"Citation": "Adar SD, D'Souza J, Mendelsohn-Victor K, Jacobs DR, Jr., Cushman M, Sheppard L, Thorne PS, Burke GL, Daviglus M, Szpiro AA, Diez Roux AV, Kaufman JD, Larson TV. Markers of Inflammation and Coagulation after Long-Term Exposure to Coarse Particulate Matter: A Cross-Sectional Analysis from the Multi-Ethnic Study of Atherosclerosis. Environ Health Perspect. 2015", "ArticleIdList": ["PMC4455582", "25616153"]}, {"Citation": "Hajat A, Allison M, Diez-Roux AV, Jenny NS, Jorgensen NW, Szpiro AA, Vedal S, Kaufman JD. Long-term Exposure to Air Pollution and Markers of Inflammation, Coagulation, and Endothelial Activation: A Repeat-measures Analysis in the Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology. 2015;26(3):310\u201320.", "ArticleIdList": ["PMC4455899", "25710246"]}, {"Citation": "Graff DW, Cascio WE, Rappold A, Zhou H, Huang YT, Devlin RB. Exposure to Concentrated Coarse Air Pollution Particles Causes Mild Cardiopulmonary Effects in Healthy Young Adults. Environmental Health Perspective. 2009;117(7):1089\u20131094.", "ArticleIdList": ["PMC2717135", "19654918"]}, {"Citation": "Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med. 2007;176(4):370\u20136.", "ArticleIdList": ["17463411"]}, {"Citation": "Rich DQ, Zareba W, Beckett W, Hopke PK, Oakes D, Frampton MW, Bisognano J, Chalupa D, Bausch J, O'Shea K, Wang Y, Utell MJ. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environ Health Perspect. 2012;120(8):1162\u20139.", "ArticleIdList": ["PMC3440073", "22542955"]}, {"Citation": "Liao D, Heiss G, Chinchilli VM, Duan Y, Folsom AR, Lin HM, Salomaa V. Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol. 2005;15(4):319\u201328.", "ArticleIdList": ["15536489"]}, {"Citation": "Chuang K-J, Yan Y-H, Chiu S-Y, Cheng T-J. Long-Term Air Pollution Exposure and Risk Factors for Cardiovascular Diseases among the Elderly in Taiwan. Occup Environ Med. 2011;68:64\u201368.", "ArticleIdList": ["20833756"]}, {"Citation": "Jenkins PL, Phillips TJ, Mulberg EJ, Hui SP. Activity patterns of Californians: use of and proximity to indoor pollutant sources. Atmos Environ. 1992;26A:2141\u20132148."}], "ReferenceList": []}], "History": [{"Year": "2017", "Month": "3", "Day": "1"}, {"Year": "2015", "Month": "11", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26600256", "NIHMS772830", "PMC4841679", "10.1097/EDE.0000000000000421"]}}], "PubmedBookArticle": []}